CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 142 enrolled
Drug / intervention
Ketorolacdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05074056
NCT05074056Phase 4Completed
CompareCT.gov

Evaluation of Perioperative Usage of Ketorolac on Postoperative Pain Reduction in Pediatric Patients with Adenotonsillectom

St. Louis University·interventional·Posted Oct 12, 2021·Updated Feb 3, 2025

In Brief

A Phase 4 clinical trial evaluating Ketorolac for Adenotonsillar Hypertrophy and 3 related conditions. Completed, enrolled 142 participants across 1 site.

Detailed Summary

Postoperative pain management in the pediatric patient undergoing tonsillectomy is challenging. Despite being used in many procedures for postoperative pain management, perioperative ketorolac usage in pediatric tonsillectomy surgery is very limited. A recent survey showed that only 8.2% of anesthesiologists use NSAIDS for perioperative management of children with OSA undergoing adenotonsillectomy. The investigators propose to conduct a prospective, randomized study to investigate the opioid-sparing effect of perioperative ketorolac in pediatric patients who undergo tonsillectomies.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdenotonsillar Hypertrophy, Obstructive Sleep Apnea, Sleep-Disordered Breathing, Acute Post Operative Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedOct 12, 2021
Enrollment StartFeb 8, 2022
Primary CompletionDec 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.7 years ago

Interventions

Ketorolacdrug

We will administer intraoperative ketorlac.